In the cumulative meta-analysis by years of publications, we observed a decreasing trend of RR for the two- and five-year all-cause mortality, indicating that paclitaxel-coated/eluting devices implemented in recent years were less toxic to patients with PAD.
← all excerpts
Safety of paclitaxel-coated devices in the femoropopliteal arteries: A systematic review and meta-analysis.
1
—
—